Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

t-cell   publishing date : 2021 - 06 - 04    save search

Kite's Tecartus® Demonstrates High Response Rate in Adults With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia Earning Priority Review Designation
Published: 2021-06-04 (Crawled : 20:00) - biospace.com/
GILD | $66.94 -0.55% -0.55% 5.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.47% H: 1.17% C: 0.96%

leukemia t-cell designation
Worldwide CAR-T Cell Therapy Industry - Featuring Aleta BioTherapeutics, Atara Biotherapeutics and BioNTech Among Others
Published: 2021-06-04 (Crawled : 16:00) - prnewswire.com
BMY | $47.84 -0.87% -0.02% 12M twitter stocktwits trandingview |
Health Technology
| | O: 0.28% H: 0.38% C: -0.06%
SRNE | $0.0275 -8.85% 53K twitter stocktwits trandingview |
Health Technology
| | O: 1.73% H: 2.43% C: -1.58%
PGEN | $1.315 -3.31% -3.42% 810K twitter stocktwits trandingview |
Health Technology
| | O: 1.07% H: 3.01% C: 0.45%
PSTX | News | $2.03 0.0% 980K twitter stocktwits trandingview |
Health Technology
| | O: -1.07% H: 2.53% C: 0.84%
MBIO | $0.373 7.74% 7.18% 440K twitter stocktwits trandingview |
Health Technology
| | O: 2.46% H: 8.41% C: 6.91%
GILD | $66.94 -0.55% -0.55% 5.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.47% H: 1.17% C: 0.96%
FATE | $5.28 -1.86% -1.89% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: 1.53% H: 9.81% C: 6.61%
BLCM | $0.0748 381.28% 6.1K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 2.74% C: 0.68%
ANIX 4 | $3.085 -2.68% -2.76% 73K twitter stocktwits trandingview |
Health Technology
| | O: 1.78% H: 6.25% C: 3.0%

therapy car-t iot t-cell
Fate Therapeutics Highlights Positive Interim Data from its Phase 1 Study of FT516 in Combination with Rituximab for B-cell Lymphoma at 2021 ASCO Annual Meeting
Published: 2021-06-04 (Crawled : 12:00) - globenewswire.com
FATE | $5.28 -1.86% -1.89% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: 1.53% H: 9.81% C: 6.61%

phase 1 positive phase 3 phase 2 t-cell
Gainers vs Losers
56% 44%

Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M twitter stocktwits trandingview |
Health Technology

SINT | $0.0365 59.39% 37.26% 470M twitter stocktwits trandingview |
Health Technology

WISA 4 | $9.19 50.66% 33.7% 65M twitter stocktwits trandingview |
Electronic Technology

EDBL | News | $6.73 47.91% 32.39% 13M twitter stocktwits trandingview |

GCTK | $0.715 36.27% 26.62% 640K twitter stocktwits trandingview |
Manufacturing

TCON | $2.33 36.26% 26.61% 2M twitter stocktwits trandingview |
Health Technology

TIRX | $0.48 6.43% 24.58% 4.8M twitter stocktwits trandingview |

KZIA | $0.38 30.58% 23.42% 300K twitter stocktwits trandingview |
Health Technology

VNDA | News | $5.23 29.14% 22.56% 24M twitter stocktwits trandingview |
Health Technology

ATNF | $1.91 29.05% 22.51% 310K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.